Company news
Microbio Co., Ltd. news
Latest news releases, newest first.
Microbio Announce on behalf of major subsidiary Cotton Field Organic Co., Ltd.on matters related to the full non-physical issuance of shares
August 17, 2022
Microbio Announce on behalf of major subsidiary Cotton Field Organic Co., Ltd. about the resolution that the Ex-rights record date of new shares from earnings by BOD
August 17, 2022
The Board of Directors Approved the 2022 Q2 Consolidated Financial Statements
August 12, 2022
Announcement of the BOD resolved to release of non-compete restrictions for the manager
August 12, 2022
Annouce the new appointment of the general manager
August 12, 2022
Microbio To announce the change of the spokesperson
July 11, 2022
Microbio: Announced BOD's resolution that the related matters of ex-rights and ex-dividend
June 30, 2022
Microbio Announce on behalf of major subsidiary Cotton Field Organic Co., Ltd.,the record date for dividend distribution.
June 10, 2022
Microbio receives a R.O.C. patent on the new drug MS-20 (CHEMO YOUNG).
June 1, 2022
Announcement on behalf of major subsidiary Cotton Field Organic Co.,Ltd. the change of the general manager
May 23, 2022
Subsidiary received the unblinding data from CRO, engaged by Oneness, regarding US Phase II clinical trial of FB825 to treat moderate-to-severe atopic dermatitis.
May 2, 2022
Announcement on behalf of major subsidiary Cotton Field Organic Co.,Ltd. for shareholders' meeting resolution of the 2022
April 29, 2022
Microbio receives a Brazil patent on the new drug MS-20 (CHEMO YOUNG).
April 15, 2022
Announcement of the resolution of the BOD to issue new shares through capitalization of capital surplus
March 15, 2022
Announcement of dividends distribution approved by the BOD
March 15, 2022
Board's resolution to convene the 2022 Annual General Meeting (Method of convening the meeting: hybrid shareholders' meeting)
March 15, 2022
Announcement of the resolution of the BOD to convene the 2022 annual shareholders' meeting
February 25, 2022
Microbio Announce on behalf of major subsidiary Cotton Field Organic Co.,Ltd. about its BOD resolution to convene the 2022 Annual Shareholders’meeting
February 24, 2022
Microbio Announce on behalf of major subsidiary Cotton Field Organic Co., Ltd. about its Board of Directors resolve dividend distribution of 2021
February 24, 2022
Microbio Announce on behalf of major subsidiary Cotton Field Organic Co.,Ltd. about its Board of Directors approved donations to related parties
February 24, 2022
Microbio Announce on behalf of major subsidiary Cotton Field Organic Co., Ltd. about its Board approved capital increase by earnings
February 24, 2022
The data of SNS812, an anti-Pan-COVID19 siRNA, co-developed by subsidiary Microbio (Shanghai) & Oneness were published today by EMBO Molecular Medicine.
February 21, 2022
Microbio receives a U.S. patent on the new drug MS-20 (CHEMO YOUNG).
February 8, 2022